These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26995334)

  • 1. Survivin, caspase-3 and MIB-1 expression in astrocytic tumors of various grades.
    Lebelt A; Rutkowski R; Och W; Jaczun K; Dziemiańczyk-Pakieła D; Milewski R; Mariak Z; Reszeć J
    Adv Med Sci; 2016 Sep; 61(2):237-243. PubMed ID: 26995334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades.
    Reszec J; Szkudlarek M; Hermanowicz A; Bernaczyk PS; Mariak Z; Chyczewski L
    Histol Histopathol; 2015 Mar; 30(3):361-71. PubMed ID: 25386667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
    Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
    Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 expression and subcellular survivin localization improve the diagnosis and prognosis of patients with diffuse astrocytic tumors.
    Faccion RS; Bernardo PS; de Lopes GPF; Bastos LS; Teixeira CL; de Oliveira JA; Fernandes PV; Dubois LG; Chimelli L; Maia RC
    Cell Oncol (Dordr); 2018 Apr; 41(2):141-157. PubMed ID: 29374392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker.
    Saito T; Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Yamasaki F; Hidaka T; Arita K; Kurisu K
    J Neurooncol; 2007 Apr; 82(2):193-8. PubMed ID: 17151933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index.
    Uematsu M; Ohsawa I; Aokage T; Nishimaki K; Matsumoto K; Takahashi H; Asoh S; Teramoto A; Ohta S
    J Neurooncol; 2005 May; 72(3):231-8. PubMed ID: 15937645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
    Matsumoto T; Fujii T; Yabe M; Oka K; Hoshi T; Sato K
    Histopathology; 1998 Nov; 33(5):446-52. PubMed ID: 9839169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors.
    Iwata S; Nakagawa K; Harada H; Oka Y; Kumon Y; Sakaki S
    Neurosurgery; 1999 Jul; 45(1):24-8; discussion 29. PubMed ID: 10414562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
    Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
    Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of chemokine receptor CXCR3 and its ligand CXCL10 in low-grade astrocytomas and glioblastoma multiforme: A tissue microarray-based comparison.
    Sharma I; Siraj F; Sharma KC; Singh A
    J Cancer Res Ther; 2016; 12(2):793-7. PubMed ID: 27461653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative index in astrocytic tumours.
    Rathi KR; Radotra BD; Khosla VK
    Indian J Pathol Microbiol; 2007 Oct; 50(4):754-8. PubMed ID: 18306542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.
    Ralte AM; Sharma MC; Karak AK; Mehta VS; Sarkar C
    Pathol Oncol Res; 2001; 7(4):267-78. PubMed ID: 11882906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
    Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
    Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cyclin A and MIB-1 expression in astrocytic tumors using image-based cell analysis system.
    Ren Y; Munyer P; Kepes JJ; Cansler M; Collins J; Gayed B; Tawfik O
    Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):14-8. PubMed ID: 11277408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
    Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
    Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome.
    Nassar A; Lawson D; Cotsonis G; Cohen C
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):113-20. PubMed ID: 18227733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of multiple genes in astrocytic gliomas.
    Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
    Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.